Document: Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (II-40)-2026/3/17

Document: Template for a request for amendments of or addition of active substances or combinations of active substances to the European Union reference-date list-2026/3/17

Page: Clinical pharmacology and pharmacokinetics: questions and answers-2026/3/17

Document: Agenda - Medicine Shortages SPOC Working Party meeting 16-17 March 2026-2026/3/17

Document: Antimicrobial Sales and Use (ASU) Power BI application user guide-2026/3/17

Document: Antimicrobial Sales and Use (ASU) platform user guide-2026/3/17

Document: Agenda - Management Board meeting: 12 March 2026-2026/3/17

Document: Records of data processing activity for women leadership development and mentoring activities-2026/3/17

Page: Stakeholders and Communication-2026/3/16

Document: HMPC: overview of assessment work - priority list-2026/3/16